Home4016 • TADAWUL
add
Middle East Pharmaceutical Inds Co SJSC
Previous close
SAR 122.40
Day range
SAR 119.80 - SAR 122.20
Year range
SAR 107.00 - SAR 144.60
Market cap
2.41B SAR
Avg Volume
35.58K
P/E ratio
26.84
Dividend yield
1.66%
Primary exchange
TADAWUL
Market news
Financials
Income Statement
Revenue
Net income
| (SAR) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 97.36M | 28.41% |
Operating expense | 38.04M | 15.13% |
Net income | 19.40M | 107.05% |
Net profit margin | 19.92 | 61.17% |
Earnings per share | — | — |
EBITDA | 24.86M | 77.00% |
Effective tax rate | 7.35% | — |
Balance Sheet
Total assets
Total liabilities
| (SAR) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 33.87M | -1.92% |
Total assets | 548.33M | 20.29% |
Total liabilities | 160.73M | 14.53% |
Total equity | 387.61M | — |
Shares outstanding | 20.00M | — |
Price to book | 6.32 | — |
Return on assets | 10.26% | — |
Return on capital | 12.48% | — |
Cash Flow
Net change in cash
| (SAR) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 19.40M | 107.05% |
Cash from operations | 23.23M | -25.41% |
Cash from investing | -7.86M | -8.11% |
Cash from financing | -4.15M | 6.76% |
Net change in cash | 11.22M | -42.22% |
Free cash flow | 7.45M | -75.23% |
About
Founded
1998
Headquarters
Website
Employees
632
